Paulo G. Kotze retweeted
🚨 Exciting news in Crohn’s disease care!
FDA approves subcutaneous SKYRIZI induction, offering patients greater flexibility and convenience.
A welcome step toward making effective IBD treatment fit patients’ lives!
#IBD #CrohnsDisease #IBDLibrary
linkedin.com/posts/ibd-crohn…
Paulo G. Kotze retweeted
🆕Updated treatment targets in inflammatory bowel disease (STRIDE-III): an initiative of the International Organization for the Study of IBD
thelancet.com/journals/langa…
#GITwitter #IBD #MedTwitter #UEGWeek @my_ueg @IOIBD1 @DignassAxel
Paulo G. Kotze retweeted
Robotic colonoscopy in action 🔦🤖🕹️
This first-in-human study presented today by Marcin Romanczyk at #UEGWeek showcases the Triton system, which uses a remotely controlled colonoscope and overtube incorporating dual dynamic rigidisation technology. By selectively stiffening flexible segments, it maintains scope configuration, minimises looping and enables precise tip deflection and rotation. This potentially improves navigation, stability and endoscopist ergonomics.
His proof of concept study included 50 patients across two phases. Caecal intubation was achieved in 100%, without repositioning, abdominal pressure or conversion to conventional colonoscopy. Median caecal intubation time was 13 minutes. Adenoma detection rate was 54.2%, with successful resection of all 77 polyps. No adverse events occurred during 14-day follow-up. This causes far less physical and mental load for the endoscopist, and in is view, is way better than conventional colonoscopy.
Could we be seeing a glimpse of the future of colonoscopy?
Paulo G. Kotze retweeted
ABBV-466: dual IL-23p19 + α4β7 targeting in Crohn's. TARGET-CD phase 2a presented by Prof Remo Panaccione at #UEGWeek2026 🧵
300 patients, 75% advanced-therapy experienced
#IBD #weareUEG
Paulo G. Kotze retweeted
Recuerdo aquel viaje en tren en el que @jp_gisbert y yo soñamos con hacer este estudio. Hoy, con su aceptación, aquel sueño se hace realidad. Un día muy especial: los sueños pueden cumplirse con ilusión y perseverancia. Gracias @geteccu y EpidemIBD team❤️ onlinelibrary.wiley.com/doi/…
Paulo G. Kotze retweeted
Join @doc_ibd and myself as we discuss the new anti TL1A pathway in #IBD. Free webinar tonight - Tues Oct 6 at 7pm ET. All welcome and it’s free to register. @ontario_gastros @CanGastroAssn @AmCollegeGastro @AmerGastroAssn @ScopeCanMD
mdbriefcase.com/webinars/imm…
Paulo G. Kotze retweeted
IBD care does not stand still. #AIBD2026 connects you with experts, knowledge and a community to understand where the field is headed and what it means for your practice today.
Celebrate 25 Years with Us.
Secure Your Spot: bit.ly/4yfNrE5
Paulo G. Kotze retweeted
Join us for next session of SCOPE Rounds Gastroenterology 2026!
📌 Surgical management of IBD: What gastroenterologists should know
👨⚕️ Dr. Paulo Kotze
🗓️ September 29 at 7:00 PM ET
👉 Register now: us02web.zoom.us/webinar/regi…
Paulo G. Kotze retweeted
Last day for Early Bird registration for #AIBD2026!
Looking forward to a great meeting—connecting with colleagues, discussing the latest advances in #IBD, and bringing together medical & surgical perspectives.
Hope to see you there!
#CrohnsDisease #UlcerativeColitis #IBD
Paulo G. Kotze retweeted
Today is the final day to save on #AIBD2026. Early Bird rates end tonight so secure your seat now: hubs.ly/Q04xVGn60
Join co-chairs @MLongMD, @MRegueiroMD and Dr. Siegel as the #IBD community comes together in Orlando to celebrate 25 years of advancing IBD care.
Paulo G. Kotze retweeted
📂Documentos
📂Copa do Brasil 2019
📂Final
📂Gol antológico
📂Cirineta
"Que lance do Cirino! Espetacular o Cirino!”
Paulo G. Kotze retweeted
Join us for next session of SCOPE Rounds Gastroenterology 2026!
📌 Surgical management of IBD: What gastroenterologists should know
👨⚕️ Dr. Paulo Kotze
🗓️ September 29 at 7:00 PM ET
👉 Register now: us02web.zoom.us/webinar/regi…
Paulo G. Kotze retweeted
Don’t miss this event with the superb @pakotze for all IBD interested surgeons and gastroenterologists. @ontario_gastros @CanGastroAssn @OAGS1 @AmCollegeGastro @AGA_Gastro @mantaj_brar @AnthonydeBuck @PhilFleshnerMD @AmCollSurgeons @ASCRS_1
Join us for next session of SCOPE Rounds Gastroenterology 2026!
📌 Surgical management of IBD: What gastroenterologists should know
👨⚕️ Dr. Paulo Kotze
🗓️ September 29 at 7:00 PM ET
👉 Register now: us02web.zoom.us/webinar/regi…
Paulo G. Kotze retweeted
Looking forward to honoring the 2026 Sherman Prize Recipients at the 25th Anniversary of #AIBD2026 this December.
Announcing the 2026 Sherman Prize Recipients: @MRegueiroMD, @bruce_sands1, & @DrSidSinha, honored for their exceptional & pioneering contributions to IBD care, research & innovation.
@StanfordGI @StanfordDeptMed @IcahnMountSinai @MountSinaiGI @DOMSinaiNYC @ClevelandClinic
Paulo G. Kotze retweeted
A robotic colonoscopy system hit 100% cecal intubation with zero major adverse events in its first human trial. Independent reviewers say wider adoption hinges on outcomes data in older, more diverse patients—not just ergonomics.
f.mtr.cool/f0z2cbtywh
#GI #Endoscopy
Paulo G. Kotze retweeted
We found that submucosal thickness of the sigmoid is more closely associated with bowel urgency in UC than mucosal thickness. #IUS @BowelUltrasound @DrSagami
onlinelibrary.wiley.com/doi/…
Paulo G. Kotze retweeted
🆕Long-term outcomes of top-down therapy versus a conventional step-up strategy in adults newly diagnosed with Crohn's disease: 5-year follow-up of the PROFILE trial
thelancet.com/journals/langa…
#GITwitter #MedTwitter



























